Literature DB >> 15929179

Interplay between nitric oxide and VIP in CCK-8-induced phasic contractile activity in the rabbit sphincter of Oddi.

Attila Pálvölgyi1, Réka Sári, József Németh, Annamária Szabolcs, István Nagy, Péter Hegyi, János Lonovics, Zoltán Szilvássy.   

Abstract

AIM: The sphincter of Oddi (SO) plays an important role in delivery of bile into the duodenum. To establish whether vasoactive intestinal polypeptide (VIP) and nitric oxide (NO) were involved in phasic contractile activity of the rabbit SO stimulated by cholecystokinin-octapeptide (CCK-8).
METHODS: Isolated SO muscle rings were cleaned of fat and mounted horizontally on two small L-shaped hooks one of which was connected to a force transducer for the measurement of isometric tension. The experiments were carried out in a thermostatically controlled (37+/-0.2 degrees) organ bath (5 mL) containing Krebs solution. The organ fluid was gassed with 95% O(2) and 50 mL/L CO(2) to keep the pH at 7.40+/-0.05. Contractile responses to CCK-8 (1 micromol/L) were evaluated in the presence and absence of N(G)-nitro-L-arginine (LNNA), an inhibitor of NO synthase (100 micromol/L), and (p-chloro-D-Phe(6)-Leu(17))-VIP (VIPa, 30 micromol/L), a VIP receptor antagonist.
RESULTS: CCK-8 stimulated the phasic activity of the SO. NO synthase inhibition increased the frequency and amplitude of contractions with a slight increase in developed tension. Pre-incubation with VIPa also attenuated this CCK-8 effect. The combined application of LNNA and VIPa abolished the phasic activity of the muscle rings with a marked increase in tension in response to CCK-8.
CONCLUSION: VIP and NO together contribute to an increase in phasic activity of SO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929179      PMCID: PMC4316060          DOI: 10.3748/wjg.v11.i21.3264

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Impaired nitrergic relaxation of the sphincter of Oddi of hyperlipidaemic rabbits.

Authors:  Z Szilvassy; I Nagy; J Szilvassy; I Jakab; S Csati; J Lonovics
Journal:  Eur J Pharmacol       Date:  1996-04-22       Impact factor: 4.432

Review 3.  Innervation of the sphincter of Oddi: physiology and considerations of pharmacological intervention in biliary dyskinesia.

Authors:  J Toouli; R A Baker
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

4.  Regulation of VIP release from rat enteric nerve terminals: evidence for a stimulatory effect of NO.

Authors:  H D Allescher; M Kurjak; A Huber; P Trudrung; V Schusdziarra
Journal:  Am J Physiol       Date:  1996-10

5.  Involvement of L-arginine-nitric oxide pathways in neural relaxation of the sphincter of Oddi.

Authors:  J G Pauletzki; K A Sharkey; J S Davison; A Bomzon; E A Shaffer
Journal:  Eur J Pharmacol       Date:  1993-03-02       Impact factor: 4.432

6.  Improvement of nitrergic relaxation by farnesol of the sphincter of Oddi from hypercholesterolaemic rabbits.

Authors:  Z Szilvassy; R Sari; J Nemeth; I Nagy; S Csati; J Lonovics
Journal:  Eur J Pharmacol       Date:  1998-07-17       Impact factor: 4.432

7.  Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.

Authors:  J Behar; P Biancani
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.

Authors:  P Vergara; Z Woskowska; S Cipris; J E Fox-Threlkeld; E E Daniel
Journal:  J Pharmacol Exp Ther       Date:  1996-10       Impact factor: 4.030

9.  Regional differences in nitric oxide-mediated relaxation of the rabbit sphincter of Oddi.

Authors:  J Lonovics; I Jakab; J Szilvássy; Z Szilvássy
Journal:  Eur J Pharmacol       Date:  1994-04-01       Impact factor: 4.432

10.  Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans.

Authors:  A Slivka; R Chuttani; D L Carr-Locke; L Kobzik; D S Bredt; J Loscalzo; J S Stamler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more
  4 in total

1.  Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.

Authors:  Zhong-Hou Rong; Hong-Yuan Chen; Xin-Xing Wang; Zhi-Yi Wang; Guo-Zhe Xian; Bang-Zhen Ma; Cheng-Kun Qin; Zhen-Hai Zhang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide.

Authors:  Zhen-Hai Zhang; Cheng-Kun Qin; Shuo-Dong Wu; Jian Xu; Xian-Ping Cui; Zhi-Yi Wang; Guo-Zhe Xian
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 3.  Neurohormonal regulation of the sphincter of Oddi.

Authors:  Charmaine M Woods; Gino T P Saccone
Journal:  Curr Gastroenterol Rep       Date:  2007-04

Review 4.  Sphincter of Oddi Function and Risk Factors for Dysfunction.

Authors:  Elham Afghani; Simon K Lo; Paul S Covington; Brooks D Cash; Stephen J Pandol
Journal:  Front Nutr       Date:  2017-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.